Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2014 5
2015 3
2016 2
2017 2
2018 7
2019 3
2020 4
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Biodistribution and Activity of EGFR Targeted Polymeric Micelles Delivering a New Inhibitor of DNA Repair to Orthotopic Colorectal Cancer Xenografts with Metastasis.
de Paiva IM, Vakili MR, Soleimani AH, Tabatabaei Dakhili SA, Munira S, Paladino M, Martin G, Jirik FR, Hall DG, Weinfeld M, Lavasanifar A. de Paiva IM, et al. Among authors: vakili mr. Mol Pharm. 2022 Jun 6;19(6):1825-1838. doi: 10.1021/acs.molpharmaceut.1c00918. Epub 2022 Mar 10. Mol Pharm. 2022. PMID: 35271294 Free PMC article.
Reduced Heart Exposure of Diclofenac by Its Polymeric Micellar Formulation Normalizes CYP-Mediated Metabolism of Arachidonic Acid Imbalance in An Adjuvant Arthritis Rat Model: Implications in Reduced Cardiovascular Side Effects of Diclofenac by Nanodrug Delivery.
Al-Lawati H, Vakili MR, Lavasanifar A, Ahmed S, Jamali F. Al-Lawati H, et al. Among authors: vakili mr. Mol Pharm. 2020 Apr 6;17(4):1377-1386. doi: 10.1021/acs.molpharmaceut.0c00069. Epub 2020 Feb 24. Mol Pharm. 2020. PMID: 32023064
Modulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug Resistance.
Soleymani Abyaneh H, Soleimani AH, Vakili MR, Soudy R, Kaur K, Cuda F, Tavassoli A, Lavasanifar A. Soleymani Abyaneh H, et al. Among authors: vakili mr. Pharmaceutics. 2018 Oct 21;10(4):196. doi: 10.3390/pharmaceutics10040196. Pharmaceutics. 2018. PMID: 30347860 Free PMC article.
29 results